© Copyright 2003 Frost & Sullivan. All Rights Reserved. U.S. Molecular Diagnostics Market Emerging Technologies and Expanded Applications of Existing Products Will Drive Market Growth Discovery and Diagnostics Group “New developments such as gene sequencing and nucleic acid amplification have revolutionized the in vitro diagnostics industry. The future success of these companies depends on the speed at which they can find expanded applications for assays.”

© Copyright 2003 Frost & Sullivan. All Rights Reserved. Industry Trends Medical communities increased dependence upon molecular diagnostic assays Increased level of automation Expanded testing menus Growing application of existing technologies Innovative products to provide physicians with more tools to diagnose and treat patients Increased level of response from industry to deal with emerging infectious disease agents

© Copyright 2003 Frost & Sullivan. All Rights Reserved. Key Features Frost & Sullivan provides: Detailed insights into recent developments Analysis of market, technology, and end-user trends Drivers, restraints, challenges, and strategic recommendations Analyst insights on technological innovations Market sizing and competitive structure analysis Market forecasts and opportunity analysis

© Copyright 2003 Frost & Sullivan. All Rights Reserved. What We Offer Coverage of the Clinical Diagnostic Industry Proven methodology encompassing extensive primary and secondary data and research Focused information and strategies that cover business and technology issues Credible data and analysis highlighting industry dynamics Winning strategies to help you create precise business plans

© Copyright 2003 Frost & Sullivan. All Rights Reserved. Who Will Benefit?  Current Market Participants  Find out how you compare to the competition  Assess current and future drivers and restraints  Determine and exploit new market share opportunities  New Entrants  Analyze challenges associated with the industry  Calculate time scales for strategy implementation  Position yourself to capitalize on the market’s unmet needs  Investment Community  Analyze long-term strategies of clinical diagnostic companies  Determine which participants will outperform the competition  Assess attractiveness of investing in clinical diagnostic industry

© Copyright 2003 Frost & Sullivan. All Rights Reserved. What’s Included Market and technology trends and developments Forecast model integrating a bottom-up approach with demand side penetration analysis Business models and alliance opportunities Incorporation of end user feedback in analysis Overview of competitive landscape and key success factors Analysis of firms likely to excel in the market Frost & Sullivan’s Market Engineering Analysis

© Copyright 2003 Frost & Sullivan. All Rights Reserved. Abbott Diagnostics Affymetrix, Inc. Bayer Diagnostics Beckman Coulter, Inc. Becton Dickinson and Co. BD Biosciences Clontech BioMerieux, Inc. Bio-Rad Laboratories, Inc. Calypte Celera Diagnostics Chiron Corp. Cytyc Corp. Diagnostics Products Corp. Key Market Participants Digene Corp. EraGen Biosciences, Inc. EXACT Sciences Corp. Gen-Probe, Inc. Genzyme Corp. Myriad Genetics, Inc. Roche Diagnostics Ortho Clinical Diagnostics, Inc. Ventana Medical Systems, Inc. Vical, Inc. Vysis, Inc.

© Copyright 2003 Frost & Sullivan. All Rights Reserved.  Call toll free 877 GO FROST ( )  Fax toll free   Visit For More Information

© Copyright 2003 Frost & Sullivan. All Rights Reserved. Contact Information Mike Olgin Sr. Account Executive Tel ______________________ Danielle White Media Relations Executive Tel ______________________ Jeff Frigstad Healthcare Awards Coordinator Tel Manoj Kenkare Research Director Healthcare & Life Sciences Tel ______________________ Ryan Goulding Growth Consulting Manager Healthcare & Life Sciences Tel: ______________________ Charlie Turnbow Director of Healthcare Sales Tel